Net Cash Provided by (Used in) Operating Activities |
-162K |
USD |
+56.3% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-15.1M |
USD |
+63.2% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
15.4M |
USD |
-62.8% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
4.29M |
shares |
-37.9% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-201K |
USD |
-117% |
Q1 2022 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
272K |
USD |
+587% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Valuation Allowance |
407K |
USD |
+35.3% |
Q4 2023 |
FY 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2023 |
Q3 2023 |
Deferred Tax Assets, Gross |
407K |
USD |
+74% |
Q4 2023 |
FY 2023 |
Deferred Income Tax Expense (Benefit) |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2024 |
Q3 2024 |
Additional Paid in Capital |
0 |
USD |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
-100% |
Q4 2023 |
FY 2023 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |